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Abstract 20 
Wholegrain oats are known to modulate the human gut microbiota and have prebiotic 21 
properties (increase the growth of some health promoting bacterial genera within the colon). 22 
Research to date mainly attributes these effects to the fibre content; however, oat is also a rich 23 
dietary source of polyphenols, which may contribute to the positive modulation of gut 24 
microbiota. In vitro anaerobic batch-culture experiments were performed over 24 h to evaluate 25 
the impact of two different doses (1 and 3 % w/v) of oat bran, matched concentrations of β-26 
glucan extract or polyphenol mix, on the human faecal microbiota composition using 16S RNA 27 
gene sequencing and short chain fatty acid analysis (SCFA). Supplementation with oats 28 
increased the abundance of Proteobacteria (p < 0.01) at 10 h, Bacteroidetes (p < 0.05) at 24h 29 
and concentrations of acetic and propionic acid increased at 10 and 24 h compared to negative 30 
control. Fermentation of the 1 % w/v oat bran resulted in significant increase in SCFA 31 
production at 24 h (86 ± 27 mM vs. 28 ± 5 mM; p < 0.05) and a bifidogenic effect, increasing 32 
the relative abundance of Bifidobacterium unassigned at 10h and Bifidobacterium adolescentis 33 
(p < 0.05) at 10 and 24 h compared to negative control. Considering the β-glucan treatment 34 
induced an increase in the phylum Bacteroidetes at 24 h, it explains the Bacteriodetes effects 35 
of oats as a food matrix. The polyphenol mix induced an increase in Enterobacteriacea family 36 
at 24 h. In conclusion, in this study, we found that oats increased bifidobacteria, acetic acid and 37 
propionic acid, and this is mediated by the synergy of all oat compounds within the complex 38 
food matrix, rather than its main bioactive β-glucan or polyphenols. Thus oats as a whole food 39 
led to the greatest impact on the microbiota. 40 
Keywords: oats, β-glucan, polyphenols, gut microbiota, 16S rRNA gene sequencing, short 41 
chain fatty acids, prebiotic, bifidogenic 42 
 43 
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1. Introduction 44 
A large body of evidence from prospective and intervention studies suggests that a diet rich in 45 
oats could significantly reduce the risk of bowel disease [1, 2], cardiovascular disease [3-5] 46 
and lowers high blood cholesterol levels [4-7]. Recent reports suggest that oats may act as a 47 
prebiotic, modulating the gut microbiota and impacting on metabolic disease risk [8, 9]. To 48 
date, it is believed that the protective effect of whole grain oats is mainly due to the presence 49 
of dietary fibre, in particular, soluble β-glucan [6, 10-12], and resistant starch [13]. β-glucan is 50 
known to lower cholesterol and bile acid absorption through formation of viscous gels in the 51 
upper gut [14] and/or directly binding of cholesterol or bile acids. Resistant starch leads to the 52 
production of short chain fatty acids (SCFA) in the colon and may also increase the growth of 53 
some health promoting bacterial genera within, such as Bifidobacterium and Lactobacillus [15-54 
18]. Species of these genera influence the cholesterol metabolism through increasing bile-salt 55 
hydrolase enzyme activity and the deconjugation of bile acids [19].  56 
Oats, however, are also rich dietary sources of polyphenols, including avenanthramides and 57 
phenolic acids [20]. These are likely to contribute to the health effects of a diet rich in oats [21-58 
23] but have not yet been examined in detail. Phenolic acids are found in three different forms 59 
within the oat food matrix: as soluble free acids, as soluble conjugates esterified to low 60 
molecular weight components such as sugars, and as insoluble bound acids esterified to high 61 
molecular weight components including lignin, cell wall polysaccharides and storage proteins 62 
[20]. A large proportion of oat polyphenols are bound via an ester bond, and hence are poorly 63 
absorbed in the upper intestine and reach the colon [24], where they may beneficially modulate 64 
the microbiota [8]. There are no esterases in human tissues that break these ester links [25]; 65 
therefore, the main catalytic site is in the colon through cinnamoyl esterase activity of human 66 
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faecal microbiota, such as Escherichia coli (three isolates), Bifidobacterium lactis and 67 
Lactobacillus gasseri (two strains) [26, 27].  68 
Gut microbiota (GM) alterations by whole grain oats have been observed in a number of in 69 
vitro fermentation models [9, 28-32] and animal studies [13, 33-35]. The fermentation of oats 70 
has led to increased Bifidobacterium, Lactobacillus [8, 9, 30, 31, 33, 34] and Bacteroides [32] 71 
populations and, at the same time decreased Clostridium [30, 33].  72 
The soluble β-glucans have been one of the most commonly studied components of oats [28, 73 
36, 37]. However, oat-derived isolated β-glucan only impacted on Bacteroides growth, not on 74 
Bifidobacterium in 24h pH-controlled anaerobic batch culture fermenters [28]. Furthermore, 75 
Crittenden et al. [38] reported that β-glucan was fermented by Bacteroides spp. but not by 76 
Lactobacillus or Bifidobacterium. The viscosity and molecular weight of β-glucan may 77 
strongly influence its ability to lead to SCFA production and act as a prebiotic [39]. 78 
Additionally, these studies have used the relatively high concentration of 1% v/w of β-glucan 79 
dose [31, 40] which is much higher than the physiological β-glucan concentration delivered 80 
from eating oats. To date, none of the oat or β-glucan in-vitro fermentation studies assessed the 81 
polyphenol content of their treatment [9, 28, 32]. Thus, little information exists on the ability 82 
of oat-derived avenanthramides, hydroxycinnamic and hydroxybenzoic acids to influence the 83 
GM. 84 
The main purpose of the present in vitro study was to examine if a physiologically relevant 85 
dose of polyphenol mix (avenanthramide, hydroxycinnamic acids and benzoic acid 86 
derivatives), β-glucan extract or digested oat bran as whole food matrix beneficially modulates 87 
the GM. Secondly, the study aimed to assess the impact of different doses of digested oat bran 88 
on the GM, notably using an oat bran that was well characterised in terms of physicochemical 89 
properties. 90 
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 91 
 92 
2. Materials and Methods 93 
2.1. Reagents 94 
All chemicals and reagents were purchased from Sigma-Aldrich Chemical Co Ltd. (Pool, 95 
Dorset, UK) or Fisher (Loughborough, Leics, UK) unless stated otherwise. Mixed-linkage β-96 
glucan kit was supplied by Megazyme Co (Wicklow, Ireland). The anaerobic jar (AnaerojarTM 97 
2,5L) and gas-generating kit (AnaeroGen TM) were obtained from Oxoid Ltd (UK), the 98 
dialysis tube from Spectrum (VWR International). Media and instruments were autoclaved at 99 
121°C for 15 min. HPLC column and guard cartridges were obtained from Phenomenex 100 
(Cheshire, UK). PowerSoil®DNA Isolation Kit was purchased from Mo Bio Laboratories, Inc 101 
(USA), the primers for the 16S rRNA gene amplification from Integrated DNA Technologies, 102 
BVBA (Belgium), AccuPrimeTM SuperMix II from Life Technologies (CA, USA), AMPure 103 
XP beads from Beckman Coulter Genomic (CA, USA).  104 
2.2. Oats and Controls 105 
The oat bran was purchased from White’s (Tandragee, Northern Ireland). The oat 106 
macronutrient composition was analysed by Campden BRI laboratories (Total carbohydrate, 107 
Available carbohydrate, Total dietary fibre- AOAC 991.43 method, Total fat – BS 4401, and 108 
protein – AOAC 981.10 method), whereas the detailed polyphenol content was measured in 109 
our laboratory at the University of Reading based on a previous method [41]. The beta-glucan 110 
method used was employed specifically to quantify 1,3:1,4-β-D-glucan. Synergy1 the 111 
oligofructose-enriched inulin was supplied by Beneo (Belgium) and 94%-β-glucan extract 112 
from Megazyme Co (Wicklow, Ireland). Polyphenols were purchased from Sigma-Aldrich 113 
Chemical Co Ltd. (Pool, Dorset, UK). 114 
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2.3. In vitro digestion of oat bran (from mouth to small intestine)  115 
The method employed was adapted from Mills et al. [42]. Oat bran was digested in vitro in 116 
three phases: the oral phase, the gastric phase and the small intestinal phase. 60 g of oat bran 117 
was mixed with 150 ml of sterile and distilled water and homogenised, transferred into a 500 118 
ml Duran bottle, and microwaved for 1 minute. In the oral phase, 20 mg of α-amylase was 119 
dissolved in 6.25 ml CaCl2 (1 mM, pH 7.0) and added to the solution, then incubated at 37°C 120 
for 30 minutes on a shaker set at 120 xg. After incubation, the pH was adjusted to 2.0 with 6 121 
M HCl solution and the gastric phase introduced by adding 2.7 g pepsin in 25 ml HCl (0.1 M) 122 
and further incubated for 2 hours under the same conditions. In the small intestinal phase, 560 123 
mg pancreatin and 3.5 g bile were mixed with 125 ml NaHCO3 (0.5 M) and dispensed into the 124 
mix. The pH was adjusted to 7.0 then incubated for 3 hours at 37 °C with shaking. Finally, the 125 
sample solution was transferred to a seamless semi-permeable 100-500 Dalton molecular 126 
weight cut-off regenerated cellulose dialysis tubing and dialysed against NaCl (0.01 M at 5°C) 127 
to remove low molecular mass digestion products. After 15 hours, the dialysis fluid was 128 
changed and the process continued for an additional 2 hours. The digested oat bran mix was 129 
collected and transferred into several 250 ml clear plastic containers, frozen to -80° and freeze-130 
dried for 5 days to remove all fluid content. 131 
2.4. Extraction and analyses of polyphenols from undigested and digested oat bran  132 
Polyphenols were extracted from undigested (raw) and digested (after in vitro digestion) oat 133 
bran in two separate fractions (i.e. free and conjugated or bound) using the method of Schar et 134 
al. [41]. The phenolic acids and avenanthramides in oat extracts were identified and quantified 135 
using a high-performance liquid chromatography (HPLC) Agilent 1100 series (Agilent 136 
Technologies Ltd) equipped with a quaternary pump, autosampler, column thermostat, sample 137 
thermostat and photo diode array detector. Compound separation was achieved by a Kinetex 138 
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biphenyl column (100 A 250 x 4.6 mm length, 5 uM particle size; Phenomenex) and using a 139 
gradient elution. Mobile phase A consisted of 0.1 % (v/v) formic acid in HPLC water (A), 140 
while mobile phase B was 0.1 % (v/v) formic acid in methanol. The following optimised 141 
gradient protocol was run: 0 min, 95% A, 5 % B; 20 min, 75 % A, 25 % B; 25 min, 74 % A, 142 
26 % B; 30 min, 65 % A, 35 % B; 40 min, 64 % A, 36 % B; 53 min, 30 % A, 70 % B; 56 min, 143 
5 % A, 95 % B; 61 min, 5 % A, 95 % B; 62 min, 95 % A, 5 % B; 65 min, 95 % A, 5 % B. The 144 
flow rate of the mobile phase was 1.0 ml/min and the sample injection volume was 20 µl [43]. 145 
The absorbance was recorded at 254, 280 and 320 nm and quantification was based on 12 point 146 
linear calibration curves (mean R2 > 0.99) and as a ratio to the internal standard (i.e. 3,5-147 
dichloro-4-hydroxybenzoic acid) to account for losses during extraction (R2 ≥ 0.99). 148 
 149 
2.4. Determination of the β-glucan content  150 
The β-glucan content was analysed with the 1,3:1,4 mixed-linkage β-glucan kit. The assay uses 151 
lichenase and β-glucosidase to metabolize β-glucan to β-gluco-oligosaccharides and 152 
subsequently glucose. Glucose then reacts with GOPOD reagent and its absorbance was 153 
measured at 510 nm by UltroSpec 1100 photo spectrometer (Scinteck Instruments LLC, USA). 154 
The final β-glucan content was calculated by the Megazyme Mega-CalcTM tool [44]. 155 
The molecular weight of the β-glucan was determined by size-exclusion HPLC. The 156 
chromatography system consisted of three serially connected columns (Shodex SB-G, Shodex 157 
SB-806M, Shodex SB-804 HQ) and an UV-MALLS-Viscometer-dRI detector. The column 158 
temperature was set at 40°C, the mobile phase was MiliQ water (Millipore, Bedford, MA) 159 
containing 0.02 % sodium azide, and the flow rate set at 0.5 ml/min. Samples were prepared at 160 
a concentration of 10 mg/ml, heated at 60°C for 3 hours under constant shaking, syringe filtered 161 
(0.45 μm PVD; Whatman, NY) and diluted to a concentration of 1 mg/ml before injection.  162 
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2.5. pH controlled faecal batch culture fermentation 163 
Substrate ability to modulate gut microbiota was determined using anaerobic, stirred, pH and 164 
temperature controlled faecal batch cultures. Batch culture fermentation vessels (300 ml 165 
volume: one vessel per treatment) were sterilised and filled with 135 ml of sterile basal medium 166 
(g/l: 2 g peptone, 2 g yeast extract, 0.1 g NaCl, 0.04 g K2HPO4, 0.04 g KH2PO4, 0.01 g 167 
MgSO4·7H2O, 0.01 g CaCl2·6H2O, 2 g NaHCO3, 2 ml Tween 80, 0.05 g Hemin (dissolved in 168 
a few drops of 1 M NaOH), 10 μl vitamin K, 0.5 g L-cysteine HCl, 0.5 g bile salts and 4ml of 169 
resazurin solution (0.02 %)). Before addition to the vessel, the medium was adjusted to pH 7.0 170 
and autoclaved. The sterile medium was gassed overnight with O2-free N2 (15 ml / min) to 171 
establish anaerobic conditions. To mimic the proximal region of the human large intestine, pH 172 
was held in the range of 6.7 - 6.9 by automatic addition of 0.5 M NaOH or 0.5 M HCl and 173 
controlled via pH meter controllers (Electrolab, UK) and the temperature was kept at 37 °C. 174 
Faecal samples were collected from three healthy female donors, who were between 25 and 40 175 
years old, with no history of bowel disorders, who had not received antibiotic treatment for at 176 
least 6 months before the study and had not consumed pre- or probiotic supplements one month 177 
before the study. All donors were informed of the study aims and procedures, and provided 178 
their verbal consent for stool samples to be used for the experiments in compliance with the 179 
ethics procedures required at the University of Reading. Samples were collected in anaerobic 180 
jars and used within one hour of collection. Samples were diluted 1:10 (w/v) with anaerobic 181 
phosphate buffer (0.1 M, pH 7.4) and homogenised in a stomacher for 2 mins; the batch culture 182 
systems were inoculated with 15 ml faecal slurry from an individual sample. The vessels were 183 
treated with the following substrate: 1 % w/v, 1.5 g digested oat bran (OAT1.5); 3 % w/v, 4.5 184 
g digested oat bran (digestibility of oats see McCane et al.[45]) (OAT4.5); 0.12 % w/v, 180 mg 185 
94 % β-glucan extract (BG); 0.01 % w/v, 1.7 mg polyphenol mix (same profile as 4.5 g digested 186 
oats) (POLY); 1 % w/v, 1.5 g Synergy1 (positive control, PC); an additional vessel was 187 
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prepared under the same conditions but without any substrate, negative control (NC) (Table 2). 188 
The Synergy 1 is an inulin enriched with oligofructose, has been proved their prebiotic effects 189 
[46]. The 3 % w/v oat was chosen as the highest dose since it would be the concentration 190 
reached by an average person consuming 60 g oat bran (i. e. assuming 30 g oat bran reaches 191 
the colon and colonic total volume is 1L) [45]. Based on this calculation, β-glucan extract and 192 
polyphenol mix treatments were matched to the dose present in 3 % w/v oat bran. Treatment 193 
with OAT1.5 was added to the experiment to monitor the impact of the oat dose on the prebiotic 194 
effect. Five millilitre samples were collected at 0, 5, 10, 24h, of which 1 ml aliquots were 195 
centrifuged at 13,000 xg for 10 min. Supernatants and pellets were stored separately at -20°C 196 
until analysis. 197 
 198 
2.6. High throughput sequencing of the gut microbiota 199 
The GM compositions and dynamics were determined using tag-encoded 16S rRNA gene 200 
MiSeq-based (Illumina, CA, USA) high throughput sequencing. DNA was extracted from 2 ml 201 
of faecal samples from fermentation vessel using power soil DNA isolation kit. The bead-202 
beating was performed in 3 cycles of 15 second each at 6.5 pulse / s. (The FastPrep-24™ 5G 203 
Instrument, MP Biomedicals). DNA concentrations and purity were determined using 204 
Nanodrop 1000 (ThermoScientific, USA). The V3 region of the 16S rRNA gene was amplified 205 
using primers compatible with the Nextera Index Kit NXt_338_F: 5’- 206 
TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGACWCCTACGGGWGGCAGCAG 207 
-3’ and NXt_518_R: 5’- 208 
GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGATTACCGCGGCTGCTGG -3’¨  209 
[47]. PCR reactions and library preparation were conducted as described in [48]. Briefly, PCR 210 
reactions containing 12 µl AccuPrime SuperMix II, 0.5 µl of each primer (10 µM), 5 µl of 211 
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genomic DNA (∼10 ng / μl), and nuclease-free water to a total volume of 20 µl were run on a 212 
SureCycler 8800 (Agilent, CA, USA). Applied cycling conditions were: denaturation at 95 °C 213 
for 2 min; 35 cycles of 95 °C for 15 s, 55 °C for 15 s and 68 °C for 40 s; followed by final 214 
elongation at 68°C for 5 min. To incorporate primers with adapters and indices, PCR reactions 215 
contained 12 µl Phusion High-Fidelity PCR Master Mix, 2 µl P5 and P7 primer, 2 µl PCR 216 
product and nuclease-free water for a total volume of 25 µl. 217 
Cycling conditions applied were: 98°C for 1 min; 12 cycles of 98°C for 10 s, 55°C for 20 s and 218 
72°C for 20 s; elongation at 72°C for 5 min. The amplified fragments with adapters and tags 219 
were purified using AMPure XP beads. Prior to library pooling, clean constructs were 220 
quantified using a Qubit fluorometer (Invitrogen, Carlsbad, CA, USA) and mixed in 221 
approximately equal concentrations to ensure even representation of reads per sample. 180 bp 222 
pair-ended MiSeq (Illumina) sequencing was then performed according to the instructions of 223 
the manufacturer. The raw dataset containing pair-ended reads with corresponding quality 224 
scores was trimmed using CLC Genomic Workbench (CLC bio, Arhus, Denmark). Trimming 225 
settings were set to a low-quality limit of 0.01, with no ambiguous nucleotides allowed, and 226 
trimming off the primer sequences. Merging overlapped reads was performed using the "Merge 227 
overlapping pairs" tool using default settings. The Quantitative Insight Into Microbial Ecology 228 
(QIIME) tool (version. 1.8.0; Open source software) was used for further analysis [49].  229 
Purging the dataset from chimeric reads was performed using USEARCH, while the usearch61 230 
method was used for Operational Taxonomic Units (OTUs) selection [50]. The Greengenes 231 
(version 12.10) 16S rRNA gene database and EzTaxon were used as reference [51, 52].  232 
High throughput sequencing yielded 12465219 sequences free from chimeric reads, providing 233 
an average ± SD of 178202 ± 80036 sequences per sample (Range 292-447040), five baseline 234 
samples and one 10h sample were excluded due to low reads (292-509). 235 
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2.7. Short-chain fatty acid analysis  236 
The defrosted supernatant samples were filtered (0.22 μm, Millipore) and spiked with 50 μl 237 
internal standard (2-ethyl butyric acid, 100 mM). SCFAs were measured in an ion exclusion 238 
HPLC system (Agilent 1100 Series) equipped with DAD detector (G-1315B), autosampler 239 
(G1316A) and Aminex HPX-8711 column (300 x 7.8mm) heated to 84°C. Samples (20 μl) 240 
were injected in duplicate, and UV absorption was measured at 214 nm. The mobile phase was 241 
2.5 mM aqueous sulphuric acid run at a flow rate of 0.6 ml/min. Peaks were integrated using 242 
Agilent ChemStation software (Agilent Technologies, Oxford, UK) and single point internal 243 
standard method. Peak identity and quantification were determined using a mixture of 244 
standards of acetic, butyric, iso-butyric, propionic, lactic, formic, valeric and isovaleric acids. 245 
Quantification was based on the 10-point calibration curve of analytical standards (R2 ≥ 0.99). 246 
2.8. Statistics 247 
For calculation of alpha and beta diversity measurement of the sequencing data, the d- and e-248 
values were set to 9800 reads per sample (85 % of the sequence number of the most indigent 249 
sample). Alpha diversity measures expressed with an observed species with Chao1, the 250 
sequence similarity 97 % OTUs value were computed for rarefied OTU tables using the alpha 251 
rarefaction workflow. Differences in alpha diversity were determined using a t-test-based 252 
approach employing the non-parametric (Monte Carlo) method (999 permutations) 253 
implemented in the compare alpha diversity workflow with QIIME. 254 
The relative distribution of the genera registered was calculated and summarised at the genus 255 
level OTU tables, followed by Principal Coordinates Analysis (PCoA) plots generated with the 256 
Jackknifed beta diversity workflow based on 10 distance matrices calculated using 10 257 
subsampled OTU tables with QIIME. The p-value and the conservative FDR-corrected p-value 258 
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for multiple comparisons are reported. 3D plots were constructed from the three primary PCs 259 
from the PCoA of the MiSeq analysis to visualise group differences in the composition of the 260 
GM. 261 
For the rest of the data analysis, GraphPad Prism statistics software package version 7 was 262 
used. One-way ANOVA was used to determine differences between fermentation treatments 263 
(OAT1.5, OAT4.5, POLY, BG) at the same time point (0, 5, 10 or 24 h), followed by the least 264 
significant difference (Bonferroni) post hoc test. A repeated measures ANOVA was used to 265 
explore the differences within the same treatment (OAT1.5, OAT4.5, POLY, BG) with all the 266 
time points (0, 5, 10 and 24 h) with Bonferroni as the post hoc test. In addition to these analyses, 267 
the p values were corrected using false discovery rate (FDR), p ≤ 0.05 was considered 268 
statistically significant. 269 
3. Results 270 
3.1. The composition of undigested and digested oat bran 271 
The macronutrient, fibre and phenolic content of undigested and digested oat bran are reported 272 
in Table 1. The in vitro oral, gastric and small intestine digestion reduced the carbohydrate 273 
content by 53 %, available carbohydrate by 62 %, while the dietary fibre and β-glucan content 274 
remained stable, losing only 2 % and 12 %, respectively. Free and conjugated, bound 275 
polyphenol compounds decreased by 48 % and 26 %, respectively.  276 
3.2. Polyphenols and β-glucan content in oat bran and extract  277 
The OAT4.5 contained 1.73 mg polyphenols (total amount of free + conjugated and bound), 278 
the POLY intervention were matched to OAT4.5 (Table 2). OAT1.5 and OAT4.5 delivered 279 
56.67 mg and 170 mg β-glucan, respectively; the BG vessel to match OAT4.5 180 mg of 94% 280 
β-glucan extract was added (Table 2). The molecular weight of the β-glucan in the digested oat 281 
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bran and the extract were similar (mean ± SD 335.5 ±1.0 % kDa and 387.3±1.0 % kDa; p > 282 
0.05).  283 
3.2. Changes in alpha and beta diversity 284 
Independent of the donor, alpha diversity decreased with oats treatments over the 24h 285 
fermentation period (Chao1 2618±15 at 0h vs. 1577±22 at 24h for OAT1.5) but was constant 286 
over time in the negative control (Chao1 2639±87 at 0h vs. 2488±77 at 24h) and POLY (Chao1 287 
2655±138 at 0h vs. 2241±320 at 24h).  288 
PCoA analyses based on unweighted UniFrac distance matrices of all samples showed a clear 289 
donor effect (Figure 1.A). However, the donor effect was no longer significant when using 290 
weighted UniFrac distance matrix analysis (ANOSIM test, Donor 1. Vs. Donor 2 p =1, Donor 291 
1 vs Donor 3 p =1, Donor 2. Vs. Donor 3 p =1, Figure 1.B). 292 
Across all samples, seven bacterial phyla were classified and one phylum designated as 293 
unassigned. Phyla composition was similar for all donors (p < 0.06), although at baseline the 294 
third donor had lower Tenericutes (p < 0.01), while the second donor had higher Actinobacteria 295 
(p < 0.05). At baseline, the bacterial communities, were dominated by Firmicutes (57-67 %) 296 
and Bacteroidetes (32-41 %), while the remaining five phyla including Actinobacteria (0.8-1.4 297 
%), Verrucomicrobia, Cyanobacteria, Tenericutes and Proteobacteria (0.4-0.9 %) constituted 298 
< 1.5 % of the community (Figure 2.).  299 
3.3. Compositional Shifts 300 
Supplementation with OAT4.5 led to a lower abundance of Firmicutes (p < 0.02) at 5 to 24 h 301 
and to an increased abundance of Proteobacteria (p < 0.01) and Bacteroidetes at 24 h compared 302 
to NC. A similar trend was observed for OAT1.5 (p values)(Figure 2).  303 
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The OAT1.5 treatment had a significant effect on the relative abundance of Actinobacteria at 304 
10 h. The relative abundance of Actinobacteria differed between OAT1.5 and OAT4.5 at 305 
baseline (1.1 % and 0.8 %, respectively). Following 10 h fermentation, Actinobacteria were 306 
almost four times higher in OAT1.5 compared to OAT4.5 (4.9 % and 1.3 %, respectively), 307 
however, differences did not persist over 24 h (4.2 % vs. 3.4 %, respectively). The treatment 308 
of BG and POLY did not promote the growth of Actinobacteria, even though their dose was 309 
matched to the OAT4.5 treatment. The PC, Synergy1 resulted in the strongest bifidogenic 310 
effect and the relative abundance of Actinobacteria (baseline 1.1 % vs. 5 h at 31.1 %, 10 h at 311 
11.5 %, p < 0.05) (Figure 2.).  312 
Focusing on changes over 24 h, the abundance of Bacteriodetes increased with BG (49.3 % vs. 313 
NC for 21 %), whereas Proteobacteria significantly decreased in comparison to the NC (14 % 314 
vs. 33.5 %). POLY treatment, the abundance of Proteobacteria increased over the course of 315 
fermentation (45 % vs. NC for 33.5 %) and decreased for Bacteriodetes (p< 0.04) (18.6 % vs. 316 
46.8 % for OAT4.5). The oats and BG treatments promoted the growth of Bacteriodetes (Figure 317 
2.).  318 
At the lower taxonomic level and across all samples, 59 genera and 69 species were identified 319 
when setting the cut-off at a relative abundance above 0.1 % of the community (Table 3). 5 h, 320 
the OAT4.5 treatment led to a significantly lower abundance of Ruminococcus (0.1 %), and 321 
Coprococcus (0.1 %) genus and, at the same time, increased the proportion of unassigned 322 
Enterobacteriaceae (61.2 %) compared to NC (25.8 %) (Table 3). Most notably, OAT1.5 323 
increased the abundance of Bifidobacterium unassigned (1.5 % vs. 0.2 for NC, p < 0.05) at 10 324 
h and Bifidobacterium adolescentis at 10 h (1.9 % vs. 0.3 % for NC, p < 0.04) and at 24 h (2 325 
% vs. 0.4 for NC, p < 0.02) (Table 3), whereas OAT4.5 did not significantly impact the relative 326 
abundance of these species due to the high standard deviation among donors. Using EzTaxon 327 
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database, we were able to further identify the species designation of several OTUs at 24 h with 328 
BG and POLY treatments. At 24 h, the BG treatment had higher abundances in Bacteroides 329 
ovatus (13.5 %), B. uniform (12.9 %) and B. xylaniosolvens (3.7 %) species, while POLY led 330 
to the most abundant levels of Enterobacteriaceae species, Hafnia alvei (21.7 %). However, 331 
these changes mediated by BG and POLY treatments were not significantly different compared 332 
to NC. 333 
 334 
3.4. Production of SCFA 335 
OAT4.5 led to a high production of total SCFA compared to NC at 10 h (98.2 ± 22 mM vs 12.8 336 
± 4 mM respectively) and 24 h (151.5 ± 43 mM vs 28.1 ± 5 mM). The concentration of butyric 337 
acid was significantly increased after 24 h fermentation of OAT1.5 (p  < 0.05), and PC at 10 h 338 
(p < 0.05) and 24 h (p < 0.01) compared to NC (Figure 3). Acetic acid was the most abundant 339 
SCFA. Both oat treatments resulted in a significant increase of acetic acid at 10 h (p < 0.01), 340 
and 24 h (p < 0.01) compared with baseline and NC (Figure 3.). At 24 h, OAT4.5, OAT1.5 and 341 
PC significantly increased the concentration of propionic acid compared to NC (48  ± 24 mM, 342 
16.7 ± 3 mM, 21 ± 9 mM and 4.5 ± 0.3 mM, respectively p < 0.01, 0.05 and 0.05, respectively). 343 
Lactic and formic acids increased upon fermentation of OAT4.5 after 10 h compared to 344 
baseline, but did not reach significance due to the large variation among donors. BG led to a 345 
small production of acetic and butyric acids (not significant) whereas POLY did not induce 346 
SCFA production. Overall, there was a dose-response effect between the two oats doses in total 347 
SCFA at 10 h (98.2 ± 22 mM vs 58 ± 19 mM respectively, p < 0.05) and 24 h (151.5 ± 43 mM 348 
vs 86.1 ± 27 mM, p < 0.05).   349 
 350 
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4. Discussion 351 
This study aimed to identify the impact of different doses of oats and its isolated bioactive 352 
compounds (i.e. β-glucan or polyphenols) on the faecal gut microbiota using in vitro systems. 353 
Digested oat bran decreased alpha diversity and had a bifidogenic effect but isolated β-glucan 354 
or polyphenol mix given at a matched dose did not induce a similar effect. (Figure 2.). This is 355 
likely to be because these compounds alone did not provide enough energy for bacterial growth. 356 
We have demonstrated that OAT1.5 significantly increased the proliferation of 357 
Bifidobacterium adolescentis (Table 3). An increase in Bifidobacterium (genus level) was 358 
reported by Connolly et al. [9] and Kedia et al. [30] after fermentation of 1 % and 5 % oat 359 
grains in similar in vitro studies. B. adolescentis has a number of benefits including prevention 360 
of the development of diabetes by stimulating insulin secretion. Furthermore B. adolescentis 361 
has the ability to synthesise and secrete the neuroactive substance gamma-aminobutyric acid 362 
(GABA). GABA facilitates communication between bacteria and the human nervous system, 363 
enabling release of other neurotransmitters from specific epithelial intestinal cells [53, 54]. Our 364 
main findings suggest that oat bran could have beneficial effects on the host through increasing 365 
the relative abundance of B. adolescentis.  366 
In accordance with the literature [55, 56], the compositional analysis of digested oat bran 367 
showed limited degradation of β-glucan in the stomach and the small intestine (Table 1). BG 368 
(180 mg – 387 kDa) did not introduce changes to Actinobacteria phyla (Figure 2.), which is 369 
supported by previous studies on β-glucan [28, 38]. However, BG tended to promote the growth 370 
of beneficial Bacteroides uniformis, Bacteroides ovatus and Bacteroides xylaniosolvens 371 
compared with NC (Table 3), which is in line with reports of Wang et al. [57]. Additionally, 372 
Hughes et al. [28] used a similar anaerobic batch culture system for fermentation of 0.5 g β-373 
glucan and also showed an increase in a member of Bacteroidetes, specifically in the 374 
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Bacteroides-Prevotella group following 24 h fermentation. However, the dose of β-glucan used 375 
by Hughes et al., was almost three times higher in concentration compared with what was 376 
found in 60 g oat bran (containing 0.17 g β-glucan), which would equate to consumption of 377 
150 g oat bran.  378 
While human digestive enzymes cannot degrade plant cell wall polysaccharides, gut 379 
xylanolytic bacteria (e.g. B. xylaniosolvens, B. uniformis and B. ovatus) can, while producing 380 
SCFA with potential health-beneficial effects [58-60]. Certain strains of B. uniformis 381 
downregulate gene and protein expression of pro-inflammatory cytokines, notably iNOS and 382 
PPAR-γ, IFN-γ, resulting in reduced inflammatory status [61], suggesting that oat β-glucan 383 
could have beneficial effects on human health. More powered studies should be applied to 384 
confirm this effect.  385 
In vitro upper gut digestion (mouth to small intestine) reduced polyphenols in the free - 386 
conjugated, bound fractions by 48 % and 26 %, respectively (Table 1). This is in agreement 387 
with findings by Dall`Asta et al. [62] on phenolic bioaccessibility in durum wheat aleurone 388 
fractions where caffeic and sinapic acids appeared as the most bioaccessible (83.3 % and 79.5 389 
%) while total ferulic acid and p-coumaric acid were less bioaccessible (29.5 % and 40.7%) 390 
with in vitro digestion. Moreover, several phenolic metabolites, including vanillic acid, 4 - and 391 
3 - hydroxyhippuric acids, sulfate-conjugates of benzoic and ferulic acids are derived from the 392 
hepatic and microbial metabolism of oat brans [41]. Schar et al. [41] found relevant 393 
concentrations in urinary excretion of 30 different phenolics, and amounted to a total excretion 394 
of 33.7 ± 7.3 μmol, suggesting that a high proportion of oat phenolics are bioavailable with 395 
absorption occurring both in the small intestine and then in the large intestine within eight hours 396 
of consumption. 397 
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In the current study, POLY did not change the abundance of the Actinobacteria phyla, which 398 
is similar to the research conducted by Gwiazdowska et al. [63], which showed that 20 μg/ml 399 
polyphenols had an effect on Bifidobacterium after 1 h incubation, but no effect at 24 h. The 400 
effects of polyphenols on microbial composition, may also be related to the fact that there is 401 
no carbohydrate energy available for this fermentation. Therefore, at least part of the change 402 
may also be due to utilisation of protein as an energy source. However, in the current study a 403 
POLY- induced increase in Enterobacteriaceae phyla and Hafnia alvei species was detected 404 
[64]. Several studies connected this group with polyphenol-degrading metabolism [65, 66]. 405 
While Wen Gu et al. [67] and Hunter et al. [68] observed that Enterobacter strains could 406 
transform ferulic acid to vanillin via the non-oxidative decarboxylation, Kuntz et al. [69] 407 
believed that the H. alvei significantly attenuated the expression of adhesion molecules and 408 
cytokine secretion (IL-8 and IL-6), resulting in reduced inflammation [69]. The higher relative 409 
abundance of Enterobacteriaceae phyla and H. alvei species in POLY and digested oat bran 410 
treatments might be associated with the metabolic activity of these microbial groups towards 411 
plant-derived polyphenols and saccharides [70].  412 
Previous oat fermentation studies have not shown significant increases in the growth of 413 
Enterobacteriaceae phyla and H. alvei species [30], most likely because the fluorescence in situ 414 
hybridisation (FISH) method used did not target Enterobacteriaceae or allow analysis at the 415 
species level. We have detected an increased presence of Proteobacteria phyla (Figure 2) in all 416 
3 vessels including NC, which might be due to the artificial conditions of batch culture systems 417 
[71, 72]. Facultative anaerobic microbes are indeed less abundant in the human colon [73] but 418 
this batch culture model may not be able to achieve a strict anaerobic environment, causing an 419 
increase in Proteobacteria phyla [72].  420 
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Despite in vitro enzymatic digestion (mimicking the digestion in the upper intestine prior to 421 
colon fermentation), the available carbohydrate content of the oat bran remained high (62 %) 422 
(Table 1). Wholegrain oats are a source of starch (60 % of the total dry matter of the oat grain), 423 
consisting of 7 % rapidly digestible starch, 22 % slowly digestible and 25 % resistant starch 424 
[74] all of which contribute to the available carbohydrates. The findings of Englyst et al. 425 
suggest that human digestive enzymes do not break down dietary resistant starch [75]. 426 
Strikingly, 30 % resistant starch type 4 also led to species level alterations in a colon and 427 
increases in B. adolescentis. [76]. A previous study [40] reported that 1 % (w/v) arabinoxylan, 428 
a dietary fibre found in wholegrain including oats, has a bifidogenic effect using a similar 24 h 429 
batch culture fermentation in vitro model, yet oats generally have about 3.8 – 13.2 % of 430 
arabinoxylan [20]. This, in combination with our findings, suggests that interactions among a 431 
wide range of dietary polysaccharides may explain the bifidogenic effect of oats [77].  432 
The current results indicate that digested oat bran treatments increase SCFA production dose-433 
dependently, with a higher dose inducing higher acetate and propionate production but lower 434 
butyrate (Figure 3.). Lactic acid disappeared at 24 h, possibly because it can be further 435 
metabolised by bacteria to acetic and propionic acids [78]. Acetate and lactate are widely 436 
produced by different bacteria; however, bifidobacteria have a distinct pathway, transforming 437 
glucose to acetate and lactate [79]. SCFA can create acidic conditions in the human colon 438 
inhibiting the growth of pathogens and reducing harmful enzyme activities in the human 439 
intestine, while they also act as an energy source for gut epithelial cells [80, 81]. Furthermore, 440 
propionate derived from carbohydrate fermentation is a substrate for gluconeogenesis in 441 
humans, and also inhibits the utilisation of acetate for cholesterol synthesis in the colon and 442 
liver [82, 83]. Therefore oat bran may have a beneficial impact on human health through SCFA 443 
production.  444 
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In previous studies [84, 85] differences were observed between the activity of pure and of food 445 
matrix derived β-glucan on small intestine digestion and lipolysis.Purified β-glucan was 446 
observed to have less gel forming capacity and a lesser effect on lipolysis and cholesterol 447 
metabolism, than the matrix derived β-glucan. In addition, dietary fibre induced SCFA 448 
production has been shown to interact with phenolics [86], where butyric acid increased the 449 
ferulic acid absorption in the colon, potentially translating to higher concentrations of ferulic 450 
acid in systemic circulation in vivo. These findings indicate positive interactions of fibres and 451 
polyphenols within the food matrix on cholesterol metabolism and the bioavailability of 452 
phenolics, and also highlights the importance of considering the structure and physicochemical 453 
properties of foods, and not just the nutrient content.  454 
In conclusion, our study has shown that oat bran as a complex food matrix beneficially 455 
increases the number of B. adolescentis and the amount of SCFA production. In contrast, a 456 
matched dose of the isolated bioactive compounds, β-glucan and other polyphenols did not 457 
show any effect on the abundance of Actinobacteria. However, by regulating the Bacteroides 458 
and Enterobacteriacea families, they may also contribute to further health benefits.  459 
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Table 1. Macronutrient, fibre and phenolic content of oat bran before and after in vitro digestion 
and bioaccessibility (%) through digestion 
Components  
 
Before 
digestion 
After  
digestion 
Bioaccessibility  
% 
Amount (g) 60 40 33 
Total Carbohydrate (g) 37.8  17.6  53 
Available Carbohydrate (g) 
 
32.6  12.5  62 
Total dietary fibre(g) 
 
5.2 5.1  2 
β-glucan (g) 1.7  1.5  12 
    
Total protein (g) 
 
7  5  29 
Fat (g) 
 
3  1.1  63 
Free+conjugated polyphenols 6.2  3.2  48 
Hydroxybenzoic acids (mg) 1.2 1.1 8 
Hydrocinnamic acids (mg) 4.6 2.1 54 
Avenanthramides (mg) 0.4 0.1 75 
    
Bound polyphenols 16.4 12.2 26 
Hydroxybenzoic acids (mg) 1 0.4 60 
Hydrocinnamic acids (mg) 15.4 11.8 23 
Avenanthramides (mg) ND ND - 
    
Total polyphenols (mg) 22.6 15.4 32 
Bioaccessibility - evaluated following in vitro upper gut digestion procedures, we have used the term 
bioavailability to indicate the percentage of compound remaining, thus available to the large gut 
microbiota. This term was first defined by Dall’Asta et al. in Nutrients 2016, 8(1), 42. 
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Table 2. In vitro fermentation treatments 
Treatment β-glucan (mg) Polyphenol (mg) 
OAT1.5 56.67 0.58 
OAT4.5 170 1.73 
BG (94% of extract) 180 0.1 
POLY ND 1.73 
PC ND ND 
NC ND ND 
Digested oat bran 1.5g (OAT1.5) and 4.5g (OAT4.5), β-glucan extract (BG), polyphenol mix (POLY), 
Synergy 1 positive control (PC) and negative control (NC), not detected (ND) 
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Table 3. Significant changes (FDR p<0.05) in relative abundance (%) of bacterial taxa at 5h, 10h and 24h of in vitro batch culture fermentation 
inoculated with faeces and administered with digested oat bran 1.5g (OAT1.5) and 4.5g (OAT4.5), β -glucan extract (BG), polyphenol mix (POLY), 
Synergy 1 (PC) and negative control (NC) as substrates. This experiment was conducted three times, with a different faecal donor used for each run. 
 
Phylum 
 
Family 
 
Genus 
 
Species 
 
Time 
 Treatment1  
OAT 
1.5 
OAT 
4.5 
BG  POLY PC NC p value 
Actinobacteria Bifidobacteriaceae Bifidobacterium adolescentis 5h 2.73±1.9 0.82±0.7 0.31±0.1 0.38±0.1 18.48±3.5* 0.39±0.2 0.001 
Firmicutes Ruminococcaceae Ruminococcus unassigned 5h 0.2±0* 0.1±0.1 0.52±0.1 0.67±0.1 0.32±0.1 0.74±0.1 0.03 
Firmicutes Lachnospiraceae Coprococcus unassigned 5h 0.2±0.1* 0.12±0* 0.48±0.2 0.44±0 0.76±0.3 0.54±0 0.02 
Proteobacteria Enterobacteriaceae unassigned unassigned 5h 55.46±8.4* 61.2±9* 23±6 31.9±8.6 11.33*±3.7 25.9±11 0.05 
Actinobacteria Bifidobacteriaceae Bifidobacterium unassigned 10h 1.17±10.1* 1.1±0.9 0.19±0.1 0.17±0.1 4.12±2.1* 0.27±0.1 0.03 
Actinobacteria Bifidobacteriaceae Bifidobacterium adolescentis 10h 1.93±0.5* 0.66±0.5 0.19±0.1 0.27±0.1 6.7±2.6* 0.26±0 0.02 
Firmicutes Ruminococcaceae unassigned unassigned 10h 4.26±5 0.05±0* 8.96±2.8 8.68±1.7 9.76±10 8.85±0.8 0.03 
Firmicutes Lachnospiraceae unassigned unassigned 10h 5.14±4 0.08±0* 10.1±2.4 8.14±5 5.11±1.2 10.1±0.2 0.03 
Firmicutes Lachnospiraceae Blautia unassigned 10h 0.35±0.1* 0.02±0* 1.39±0.3 1.21±0.4 1.15±0.8 1.14±0.4 0.03 
Proteobacteria Enterobacteriaceae unassigned unassigned 10h 50.2±12.2 67.2±14* 12.75±6* 36.1±9.2 6.47±3.7* 29.2±1.4 0.02 
Actinobacteria Bifidobacteriaceae Bifidobacterium adolescentis 24h 2.03±0.1* 1.91±1.8 0.31±0.1 0.31±0.2 6.87±3.7 0.41±0 0.05 
             
1 The difference in relative abundance of taxa between treatments within the same time points was assessed by ANOVA The p-value after correction for multiple tests (69taxa) with the 
FDR method.   
* indicate significant differences (p<0.05) to NC at the same time point. Values are mean ± SE 
  30 
 
  31 
 
Figure Legend 
Figure 1. Principal coordinates analysis (PCoA) plots of 16S rRNA gene profiles based on (A) 
unweighted and (B) weighted phylogenetic Unifrac distance matrices calculated from 10 
rarefied OTU tables (9800 reads per samples) unweighted (A) showing clear clustering 
according to donors (ANOSIM test, p = 0.01). The degree of variation between 10 jackknifed 
replicates of PCoA is displayed with confidence ellipsoids around each sample. Weighted (B) 
quantitative information used to generate the bacterial relative abundance of donors showed no 
clear clustering (ANOSIM test, p >0.05) for a whole dataset (24h in vitro batch culture 
fermentation inoculated with 3 healthy donors faeces and administered with digested oat bran 
1.5g (OAT1.5) and 4.5g (OAT4.5), β-glucan extract (BG), polyphenol mix (POLY), Synergy 
1 (PC) and negative control (NC) as the substrates). Each colour represents a different donor 
Figure 2. Changes in bacterial phyla (relative abundances (%)) 0, 5, 10 and 24h in vitro batch 
culture fermentation. This experiment was conducted three times, with a different faecal donor used 
for each run. The media was supplemented with digested oat bran 1.5g (OAT1.5) and 4.5g 
(OAT4.5), β-glucan extract (BG), polyphenol mix (POLY), Synergy 1 (PC) and negative 
control (NC). Samples were analysed at 0, 5, 10, 24 h. Values are mean (%).  
Figure 3. Change in concentrations of acetic acid (A), propionic acid (B), butyric acid (C) from 
negative control (mM) throughout 24h in vitro batch culture fermentation. This experiment was 
conducted three times, with a different faecal donor used for each run. The media supplemented with 
digested oat bran 1.5g (OAT1.5) and 4.5g (OAT4.5), β-glucan extract (BG), polyphenol mix 
(POLY), Synergy 1 (PC) as the substrates. Samples were analysed at 0, 5, 10, 24 h  
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Figure 3. 
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Values are reported after subtracted of negative control value 
Significant from initial value *p < 0.05, **p< 0.01; Significant from 5h value #p < 0.05, ##p< 0.01, 
Significant from 10h value ^p < 0.05, ^^p< 0.01; Significant from negative control value at the same time 
point &p < 0.05, &&p< 0.01  
